Koyfin Home > Directory > Health Care > Adma Biologics > Total Revenue

Adma Biologics Total Revenue Chart (ADMA)

Adma Biologics annual/quarterly Total Revenue from 2011 to 2020. Revenue is the money that a business receives from its normal business activities, usually from the sale of goods and services to customers.
  • Adma Biologics Total Revenue for the quarter ending June 06, 2020 was $8m a 7.26% increase of 1m year over year
  • Adma Biologics Total Revenue for the last 12 months ending June 06, 2020 was $37m a 42.63% increase of 16m year over year
  • Adma Biologics Annual Total Revenue for 2019 was $29m a 42.13% increase of 12m from 2018
  • Adma Biologics Annual Total Revenue for 2018 was $17m a 7.21% increase of 1m from 2017
  • Adma Biologics Annual Total Revenue for 2017 was $16m a 32.36% increase of 5m from 2016
Other Income Statement Metrics:
  • Adma Biologics EBITDA for the quarter ending December 12, 2018 was $-16m a -0.51% increase of 0m year over year
  • Adma Biologics Net Income for the quarter ending December 12, 2018 was $-18m a 1.20% decrease of 0m year over year
View Chart On Koyfin

Quarterly ADMA Total Revenue Data

06/2020$8m
03/2020$10m
12/2019$12m
09/2019$7m
06/2019$7m
03/2019$4m
12/2018$4m
09/2018$4m
06/2018$5m
03/2018$4m

Annual ADMA Total Revenue Data

2019$29m
2018$17m
2017$16m
2016$11m
2015$7m
2014$6m
2013$3m
2012$1m
2011$1m